Over-the-Counter-Drugs for the Treatment of Mood and Anxiety Disorders – The Views of German Pharmacists

Abstract

Introduction: Depression, anxiety, agitation and sleep disorders are highly prevalent in the general population, but few persons receive psychiatric care.

Methods: Our aim was to study the views of 690 German pharmacists on “over-the counter” (OTC) drugs for these indications.

Results: They reported dispensing OTC medication to an average of 12 customers per day, and this corresponded to almost one quarter of the medications provided for these indications. Herbal drugs and complex homeopathic formulations were used most frequently. Patients preferring OTC substances were described as being younger, with shorter durations of illness and less severe symptoms, and more skeptical regarding psychopharmacology. While genuine pharmacological effects were considered as most relevant, pharmacists were highly aware of placebo and interpersonal factors. Symptoms, comorbidity and advice on drug intake were prominent topics during pharmacy consultations.

Conclusion: German pharmacists report dispensing large amounts of OTC drugs for anxiety, agitation, sleep disturbances or depression. It is unclear whether this constitutes a rational and cost effective method to deal with mild courses of high prevalence diseases or must be seen critically.

Key words

anxiety disorders - depression treatment - drug-seeking behavior

• References

• 1 Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharm 2005; 15: 357-376
• 2 Bijl RV, de Graaf R, Hiripi E et al. The prevalence of treated and untreated mental disorders in five countries. Health Aff 2003; 22: 122-133
• 3 Jorm AF, Griffiths KM, Christensen H et al. Actions taken to cope with depression at different levels of severity: a community survey. Psychol Med 2004; 34: 293-299
• 4 Kessler RC, Soukup J, Davis RB et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 2001; 158: 289-294
• 5 Landesapothekerkammer . Die Bayerischen Apotheken – Statistische Daten 2012. In: München: 2012
• 6 Linde K, Berner MM, Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev 2008; CD000448
• 7 Perry R, Terry R, Watson LK et al. Is lavender an anxiolytic drug? A systematic review of randomised clinical trials. Phytomedicine 2012; 19: 825-835
• 8 Pilkington K, Kirkwood G, Rampes H et al. Homeopathy for depression: a systematic review of the research evidence. Homeopathy 2005; 94: 153-163
• 9 Bonne O, Shemer Y, Gorali Y et al. A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. J Clin Psychiatry 2003; 64: 282-287
• 10 Sarris J, Moylan S, Camfield DA et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence. Evid Based Complement Alternat Med 2012; 809653
• 11 Pilkington K, Kirkwood G, Rampes H et al. Homeopathy for anxiety and anxiety disorders: a systematic review of the research. Homeopathy 2006; 95: 151-162
• 12 Teixeira MZ, Guedes CH, Barreto PV et al. The placebo effect and homeopathy. Homeopathy 2010; 99: 119-129
• 13 Linden M, Wurzendorf K, Ploch M et al. Self medication with St. John’s wort in depressive disorders: an observational study in community pharmacies. J Aff Dis 2008; 107: 205-210
• 14 Di YM, Li CG, Xue CC et al. Clinical drugs that interact with St. John’s wort and implication in drug development. Curr Pharm Des 2008; 14: 1723-1742
• 15 Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ 2012; 13: 769-776